Prognostic Significance of Circulating and Endothelial Progenitor Cell Markers in Type 2 Diabetic Foot

Table 2

Cytofluorimetric classes in all studied groups (mean ± SE): nonmacrovascular neuropathic diabetic patients without foot lesions (N); nonmacrovascular neuropathic diabetic patients with foot lesions (N1); macrovascular neuropathic diabetic patients with ulcers/lesions/osteomyelitis of the lower limbs (N2). Healthy controls (C).

	C (8)	N (14)	N1 (20)	N2 (28)
CD34+	515±57	235±18^*#	369±34 *°	280±24^*
CD133+	1970±268	497±81^**	686±80^**	508±75^**
CD34+45−	41±5^∧	21±3	51±9^∧	41±3^∧
CD34+31+	273±59^∧∧	70±9	175±34^∧	132±19^∧
CD133+31+	829±112	248±69^**	339±53^**	269±51^**
CD133+KDR+	122±34	16±5^**	26±6^**	26±10^**

∗C  versus N, N1, N2 𝑃<0.03; ^#N versus N1 𝑃<0.004; °N1 versus N2 𝑃<0.03; ^**C  versus N, N1, N2 𝑃<0.0006;  ∧N versus N1, N2, C  𝑃<0.04; ∧∧N2 versus C  𝑃<0.005.